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Abstract. Two peroxisome targeting signals (PTSs) 
for matrix proteins have been well defined to date. 
PTS1 comprises a COOH-terminal tdpeptide, SKL, 
and has been found in several matrix proteins, 
whereas PTS2 has been found only in peroxisomal 
thiolase and is contained within an NH2-terminal cleav- 
able presequence. We have investigated the functional 
integrity of the import routes for PTS1 and PTS2 in 
fibroblasts from patients uffering from peroxisome as- 
sembly disorders. Three of the five complementation 
groups tested showed a general oss of PTS1 and PTS2 
import. Two complementation groups showed a 
differential loss of peroxisomal protein import: group I 
cells were able to import a PTS1- but not a PTS2- 
containing reporter protein into their peroxisomes, and 
group IV cells were able to import the PTS2 but not 
the PTS1 reporter into aberrant, peroxisomal ghostlike 
structures. The observation that the PTS2 import path- 
way is intact only in group IV cells is supported by 
the protection of endogenous thiolase from protease 
degradation i  group IV cells and its sensitivity in the 
remaining complementation groups, including the par- 
tialized disorder of group I. The functionality of the 
PTS2 import pathway and colocalization of endoge- 
nous thiolase with the peroxisomal membranes in
group IV cells was substantiated further using im- 
munofluorescence, subcellular fractionation, and im- 
munoelectron microscopy. The phenotypes of group I 
and IV cells provide the first evidence for differential 
import deficiencies in higher eukaryotes. These pheno- 
types are analogous to those found in Saccharomyces 
cerevisiae peroxisome assembly mutants. 
p EROXISOMES are ubiquitous ubcellular organelles bounded by a single membrane. Although their 
protein content varies depending on the organism and 
cell type (Tolbert, 1981), a feature common to all peroxi- 
somes is the presence in the matrix of hydrogen perox- 
ide-producing oxidases and other enzymes required for 
/3-oxidation, and catalase. A variety of other biochemical 
functions has been assigned to peroxisomes (Lazarow, 1987; 
Van den Bosch et al., 1992; Mannaerts and Van Veldhoven, 
1993), and their importance for cellular metabolism has 
been underlined by the occurrence ofsevere disorders in man 
caused by deficiencies in peroxisomal functions (Kelley et 
al., 1986; Schutgens et al., 1986; Wanders et al., 1988; 
Lazarow and Moser, 1989; Zellweger, 1989). These dis- 
eases fall into three categories: (a) the generalized isorders 
of peroxisome assembly, in which all peroxisomal functions 
investigated are deficient; (b) the partialized disorders of 
peroxisome assembly, in which the activity of a limited sub- 
set of peroxisomal enzymes is deficient; and (c) disorders 
caused by a deficiency of a single peroxisomal enzyme. 
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Complementation studies based on the recovery of peroxi- 
somal function after fusion of certain combinations of pa- 
tients' fibroblasts indicate that the peroxisome assembly dis- 
orders are genetically heterogeneous (Brul et al., 1988; 
Roscher et al., 1989; Poll-The et al., 1990; Yajima et al., 
1992). The complementation groups established by three re- 
search groups have recently been integrated (Shimozawa et 
al., 1993), and we have investigated protein import into 
peroxisomes in four of these complementation groups. The 
fibroblasts belonging to these complementation groups, 
which we refer to using the Amsterdam nomenclature, are 
derived from patients uffering from the generalized impair- 
merits of peroxisome assembly. Morphologically distin- 
guishable peroxisomes, visualized as particle-bound cata- 
lase, are virtually absent (Goldfischer et al., 1973). 
Immunoblots have shown that the levels of the/~-oxidation 
enzymes are strongly reduced ('Pager et al,, 1985; Suzuki et 
al., 1986; Suzuki et al., 1988), and these proteins are 
thought o be degraded in the absence of import into peroxi- 
seines. At least some peroxisomal membrane proteins, how- 
ever, are present in atypical structures that have been.termed 
ghosts (Santos et al., 1988a, 1988b; Wiemer et al., 1989). 
In electron micrographs, these structures are two to four 
times larger than peroxisomes from control cells, and they 
appear to lack content (Santos et al., 1988a). Subcellular 
fractionation experiments have shown that peroxisomal 
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ghosts fractionate ata lower density than peroxisomes from 
control cells (Santos et al., 1988a; Gartner et al., 1991; Van 
Roermund et al., 1991). 
In addition to the generalized disorders of peroxisome as- 
sembly, in our analysis, we have also included cells derived 
from patients suffering from a partialized isorder of peroxi- 
some assembly: rhizomelic chondrodysplasia punctata 
(RCDP) 1 (Heymans et al., 1985 and 1986; Hoefler et al., 
1988; Poulos et al., 1988), which comprises our com- 
plementation group I (Brul et al., 1988; Heikoop et al., 
1992c). Classical RCDP is characterized biochemically by 
the following features: first, there is a deficiency of the first 
two enzymes of plasmalogen biosynthesis; econd, there is 
an inability to catabolize phytanic acid, and finally, there is 
a failure to convert the precursor form of thiolase to the ma- 
ture form of the enzyme. The morphology of peroxisomes, 
however, appears to be normal in RCDP fibroblasts (Hei- 
koop et al., 1991), and catalase ispresent in the matrix. Sub- 
cellular fractionation has shown that the peroxisomes from 
RCDP fibroblasts fractionate at the same density as peroxi- 
somes from control cells, while precursor thiolase is present 
in lower density fractions in RCDP cells (Balfe et al., 1990; 
Singh et all., 1991; Heikoop et al., 1992a). 
The aim of our research was to further analyze the mutant 
phenotypes in each of the complementation groups by inves- 
tigating the functional integrity of the import routes for the 
two well-defined peroxisome targeting signals (PTS) for ma- 
trix proteins: the PTS1 is comprised of a COOH-terminal 
tripeptide, SKL, and derivatives thereof. The PTS1 was first 
found at the COOH terminus of the firefly enzyme luciferase 
(Gould et al., 1987), and the PTS1 has since been found on 
a number of peroxisomal matrix proteins (Gould et al., 
1988). The PTS2 was first identified on rat 3-ketoacyl-CoA 
thiolase (Swinkels et al., 1991; Osumi et al., 1991), and is 
located within an NH2-terminal sequence that in mammals 
is cleavable. That proteins containing either PTS1 or PTS2 
enter the peroxisome by different import routes is reflected 
by the phenotypes ofsome of the yeast peroxisome assembly 
mutants: Saccharomyces cerevisiae pas7 can import SKL 
proteins but not thiolase into its peroxisomes (Van der Leij 
et al., 1992; Erdmann and Ktmau, 1993), and S. cerevisiae 
paslO (Van der Leij et al., 1992, 1993) and t~chiapastoris 
pas8 (McCollum et al., 1993) can import thiolase but not 
SKL proteins. In other complementation groups, neither 
thiolase nor SKL proteins are imported (Van der Leij et al., 
1992; Zhang et al., 1993). How the peroxisomal membrane 
proteins are targeted to the organelle is still unknown, and 
additional ITS motifs for this class of proteins remain to be 
identified. 
We have investigated import via the PTS1 in human fibro- 
blasts using luciferase as a reporter protein. A prethio- 
lase-cldoramphenicol acetyltransferase (CAT) fusion pro- 
tein was used as a reporter for import via the PTS2 route. 
The reporter proteins were produced from expression con- 
structs introduced into the nucleus of cells by microinjec- 
tion. Our investigation into the PTS1 and PTS2 import routes 
1. Abbreviations used in this paper: CAT, chioramphenicol acetyltransfer- 
ase; PAF, peroxisome-assembly factor; PMP, peroxisome membrane pro- 
tein; PTS, peroxisome targeting signal; RCDP, rhizomelic form of chow 
drodysplasia punctata; TRITC, Texas red isothiocyanate. 
shows that phenotypes analogous to those of the yeast mu- 
tants can be found among the human peroxisome assembly 
disorders. The observation that either one of the import 
routes can be deficient provides the first evidence that he two 
import routes for matrix proteins can be impaired indepen- 
dently of each other in the human peroxisome assembly dis- 
orders. 
Materials and Methods 
Cell Cultures 
Cultured primary skin tibroblasts used in these studies were from two con- 
trol subjects (cell lines 85AD5035F and HENG90AD) and from patients 
suffering from the clinical and biochemical features characteristic of the fol- 
lowing peroxisomal disorders: (a) RCDP, complementation group I (cell 
lines MCHE 85AD and GJOLD90AD); (b) Zellweger syndrome, com- 
plementation group II (cell lines W78/515 and BOV 84AD), group Ill 
(GOM 85AD and GM 4340), and group V (GRO 87AD); (c) hyperpipecolic 
aeidemia, group lI (cell line GM 3605); (d), the neonatal form of 
adrenoleukodystrophy, group IV (cell line AAL 85AD). Cells were grown 
in a 1:1 mixture of Dulbeceo's modified Eagle's medium and Ham's F10 
(Gibco Laboratories, Glasgow, United Kingdom) supplemented with 10% 
fetalcalf serum (Gibco Laboratories) under 5% CO2. Cells were split 1:4 
as soon as they reached confluence, as allowing the cells to remain confluent 
has been shown to increase the amount of immunoreactive thiolase in the 
cells (Wiemer et al., 1991). Cells were not used above passage 30, as an 
increased frequency of punctate fluorescence has been observed in aging 
cells (unpublished observations). 
Microinjection 
24 h before microinjection, the cells were plated onto microinjection grids. 
The needles were made using a micropipette puller (PB-7; Narishage Co., 
Tokyo), and DNA was injected in reverse PBS (4 mM Na2HPO, dl mM 
KI-I2PO4]I40 mM KC1, pH 7.3). DNA was injected at a concentration f 
"-4).1 #g/ml, which is equivalent to "°50 mol DNA per injection. 18 h after 
microinjection, the cells were processed for immunofluorescence micros- 
copy. Approximately 200 cells were injected per cell line per experiment, 
'~20 % of which survived injection and gave rise to detectable expression. 
SubceUular Fractionation 
Seven to nine 150-cm 2 flasks of cells were used per gradient. The cells 
were harvested by gentle trypsinization a d collected by low-speed centrifu- 
gation. The cells were then washed twice in PBS and once in ice-cold 
homogenization buffer (0.25 mM sucrose/0.1 mM EDTA/1 mM Tris-HCl, 
pH 7.8), and postnuclear supernatants were prepared as previously de- 
scribed (Van Roermund et al., 1991). Subsequently, equilibrium density 
centrifugation was performed as described (Van Rocrmund et al., 1991) by 
layering 4ml of the pestuuclear supernatant (containing '~25 nag of protein) 
on top of a preformed 33-ml gradient of Nycodenz (10-35 %). All Nyendenz 
solutions were prepared in homogenization buffer. Centrifugatiun was car- 
ried out in an MSE-Europe 24M centrifuge (M.S.E. Scientific Instruments, 
Crawley, United Kingdom) equipped with a ve~cal rotor for 90 rain at 
19,000 rpm at 4°C. Fractions were collected from the bottom of the gradi- 
ent and analyzed for the activity of the marker enzymes glutamate deby- 
drogenase (mitochondria), catalase (peroxisomes), and/3-hexosaminidase 
(lysosomes). Activities are expressed as percentages of total activity across 
the gradient. 
Proteinase K Protection 
The proteinase K protection experiments were performed on fibroblasts per- 
meabilized by 125 ~g/ral digitonin in permeabllization buffer. After har- 
vesting the cells by trypsinization, the fibroblasts were washed twice in cold 
PBS and resuspended to a protein concentration f '~1 mg/ml in isotonic 
sucrose buffer (250 mM sucrose, 20 mM MOPS, pH 7.4), containing 125 
#g/mi digitonin (penneabillzation buffer). The fibroblasts were then in- 
cubated for 5 min at 37°C in the digitonin permeabilizatinn buffer, as previ- 
ously described (Heikoop et al., 1990). This concentration f digitonin 
causes rupture of the plasma membrane (and perhaps also some intracellu- 
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lar membranes) (Wanders et al., 1984), whereas the peroxisomal membrane 
remains intact (Wanders ct al., 1984; Aikawa ct al., 1991). This is indicated 
by the fact that the cytosolic marker lactate dehydrogenase was present in 
the soluble fraction, whereas eatalase activity was present in the sediment- 
able fraction (10,000 g, 5 min) of both control and RCDP cells. After per- 
meab'dization of the plasma membrane, the protease protection assay was 
carried out on ice using a proteinase K concentration f 40/~g/ml in the 
presence or absence of 0.2 % Triton X-100. Samples were removed after 0. 5, 
1, and 1.5 h, and proteinase K action was stopped by addition of PMSF to 
10 raM. Protection of thiolase was assessed by immunoblot analysis. 
Immunoblot Analysis 
Samples were subjected to electrophoresis on 10% polyacrylamide g ls ac- 
cording to the method of Iatemmli. lmmunoblot analyses were performed 
as described previously with the following modifications: Nonspecific bind- 
ing sites were blocked overnight with 10% fetal calf serum in TBS (10 mM 
Tris pH 8/150 mM NaC1) containing 0.2% Tween 20. The primary (poly- 
clonal antithiolase) (Heikoop et ai., 1990) and secondary (horse radish per- 
oxidase coupled to goat anti-rabbit IgG 0Bio-Rad Laboratories, Richmond, 
CA) antibody incubations were performed in TBS containing 4% fetal calf 
serum and 0.1% Tween 20. After each incubation, the blots were washed 
extensively inTBS containing 0.1% Tween 20. Antigen-antibody complexes 
were visualized using the electrochemilumineseence kit from Amersbam 
International (Den Bosch, The Netherlands). 
Immunofluorescence Microscopy 
For labeling of the peroxisomal compartment, cells were washed in PBS and 
fixed in freshly prepared 2% (wt/vol) p-formaidehyde/0.1% Triton X-100/ 
PBS (pH 7.5) for 20 rain at room temperature. For differential permeabfliza- 
tion, the ceils were fixed in 2 % paraformaldehyde in PBS for 20 rain and 
permeabilized with 25/~g/mi digitonin in PBS (which permeabflizes the 
plasma membrane only) or 25/Lg/ml digitonin in PBS containing 0.1% Tri- 
ton X-100 (to permeabilize both the plasma membrane and the peroxisomal 
membrane). 25/~g/ml digitonin is sufficient o permeabilize the plasma 
membrane ofadhering cells because of the relatively low protein concentra- 
tion (125 ~g/ml was used to permeabilize c lls in suspension ata protein 
concentration f 1 mg/mi [see section on "Proteinase K Protection"]). For 
double labeling of peroxisomes and lysosomes, the cells were fixed by a 10- 
win incubation at room temperature in 4 mi 3 % paraformaldebyde in PBS, 
pH 7.5, followed by a 5-rain incubation a~er addition to the 4 ml parafor- 
maldehyde of 2 ml cold (-20%) methanol, followed by a final 5-rain incuba- 
tion after a further addition of 2 ml cold methanol. The fixative was then 
aspirated, and the cells were washed three times in PBS containing 0.05 % 
Triton X-100. 
Free aldehyde groups were blocked by incubating for 10 min in 0.1 M 
NI-~C1 in PBS. The cells were then processed for single- or double-label 
indirect immunofluorescence using the following antibodies: mouse mono- 
clonal antithiolase (3G4) (Heikoop et al., 1991), polyclonal anti-69-kD 
peroxisomaI membrane protein (PMP) 0~ster et al., 1986) (a kind gift 
from Dr. W. Just, Institut fiir Biochemie, Heidelberg, Germany), polyclonal 
(guinea pig) antiluciferase (Keller et al., 1987), and pelycfonal (rabbit) 
anti-chloramphenicol acetyltransferase (Sanvertecb, Boechout, Belgium). 
For double labeling of luciferase and 69-kD PMP, 69-kD PMP was visual- 
ized with FITC-conjugated donkey anti-rabbit (Jackson ImmunoResearcb 
Laboratories, West Grove, PA), and luciferase was visualized using bi- 
otinylated goat anti-guinea pig IgG (Sigma lmmunochemicals, Bornam, 
Belgium) followed by streptavidin-labeled Texas red isothiocyanate 
(TRITC) (Amersham International). For double labeling of either 69-kD 
PMP or prethiolase-CAT with monoclonal ntithiolase antibodies, the sec- 
ondary antibodies used were FITC-conjugated donkey anti-rabbit IgG 
(Jackson ImmunoResearch Laboratories) and biotinylated sheep anti- 
mouse Ig (Amersham International), followed by streptavidin-labeled 
TRH~ (Amersham International). For double labeling of peroxisomai thio- 
lase and lysosomai glucocerebrosidase, peroxisomal thiolase was visualized 
with biol~ylated sheep anti-mouse Ig (Amersbam International) followed 
by streptavidin-labeled TRITC (Amersbam International), and lysosomes 
were visualized using rabbit antiglucocerebrosidase (kind gift from Dr. H. 
Aerts, E. C Slater Institute, Amsterdam) followed by FITC-coujugated dun- 
key anti-rabbit IgG (Jackson ImmunoResearch Laboratories). For single 
labeling, biotinylated secondary antibodies were used followed by strepta- 
vidin-labeled FITC (Life, Breda, The Netherlands). 
The incubations were all performed at room temperature for 45 rain in 
PBS containing l0 mg/mi bovine serum albumin (to reduce nonspecific 
binding). After each incubation, the ceils were washed extensively in PBS. 
The injection grids were mounted on coverslips in carbonate-buffered 
glycerol containing p-phenylenediamine. The fluorescent s aining pattern 
was viewed in a fluorescence microscope (model IM'I2; Olympus Corp., 
Lake Success, NY), using an IMT2DMB filter for excitation of the FITC 
signal, and an IMT2-DMG for excitation of the TRITC signal. FITC 
fluorescence was visualized in combination with the G520 barrier filter and 
TRII~ fluorescence in combination with the 13610 barrier filter. Fluores- 
cent images were recorded on AGFA 400 ASA slide film or Kodak TMAX 
400 ASA B/W film. 
Electron Microscopy 
Fixation of fibmblasts and preparation of ultrathin cryusections were per- 
formed exactly as described by Wiemer et ai. (1989). Immunolabeling was 
performed as described previously with the following modifications. For 
double labeling with anti-69 kD PMP (rabbit polyclonal) and anfithiolase 
(mouse monoclonal), the sections were first incubated with antithiolase fol- 
lowed by rabbit anti-mouse IgG, followed by protein A-conjugated, 1O-nm 
colloidal gold. Residual binding sites were blocked with protein A. Sec- 
ondly, the sections were incubated with anti-69 kD PMP followed by pro- 
tein A conjugated with 5 nm of colloidal gold. Afar each incubation the 
grids were washed with PBS. The tissue sections mounted on the grids were 
poststained and embedded in a 0.3% uranyl acetate/1.5% mcthylcellniose 
mixture and dried in air. Grids were examined under a transmission elec- 
tron microscope (model 420; Philips Electronic Instruments, Inc., Mah- 
wah, NJ). 
Construction of Vectors 
The construction of pCDNALuc was as follows: the luciferase ORF was 
cut out of pDDR (Riggs and Chrispeels, 1987) with Sinai and HindIII, and 
the ends of this fragment were made blunt with the Klenow fragment of 
DNA polymerase I. BstXI adaptors were ligated to this fragment, which 
was then cloned into the BstXI site of the expression vector pCDNA. The 
expression plasmid encoding the first 15 amino acids of rat thiolase fused 
onto bacterial chloramphenicol acetyltrausferase (pRSV-FLT3-CAT) was a 
kind gift from S. Subramani (University of California, San Diego, CA) and 
is described by Swinkels et al. (1991). 
Results 
Our strategy to investigate peroxisomal protein import in the 
peroxisome assembly disorders involved microinjection into 
the nucleus of expression constructs encoding reporter pro- 
reins for the PTS1 or PTS2 import routes. We chose to 
microinject DNA rather than RNA or protein because the 
prolonged expression period after microinjection of DNA al- 
lows the cells time to recover from the trauma of microinjec- 
tion before detection of the antigen by immunofluorescence. 
Expression of luciferase could still be detected 48 h after 
microinjection of the DNA. Microinjection trauma is mini- 
realized because only '~50 molecules of DNA need to be 
CMV l~ Ludferase 
= - ~"  _ " " _ ' pA  
RSV ~ Preth io-CAT 
pA 
Figure 1. Constructs used to determine import via the PTS1 (lu- 
ciferase) or PTS2 (prethiolase-CAT) import routes. Stippled boxes, 
reading frames of the reporter proteins; thin lines, plasmid se- 
quences; • ,  the promoter (CMV, cytomegalovirus; ~ Rous sar- 
coma virus); pA, the polyadenylation sequence. For details of con- 
struction, see Materials and Methods. 
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Table L Targeting ofLuciferase and Prethiolase-CAT 
in Complementation Groups I-V 
Complementation group according 
to nomenclature of: 
Targeting of Targeting of 
Amsterdam Baltimore Oifu luciferase prethiolase-CAT 
I (RCDP) +*  - 
I I  1 E - - 
H I  4 C - - 
IV 2 - - +* 
V - F - +* 
Our complementation groups have been integrated with those of Baltimore 
(Roschex et al., 1989) and Gifu (Yajima et at., 1992) by Shimozawa et al. 
(1993). 
° Import into peroxisomes that appear morphologically normal and contain 
catainse (Heikoop et el., 1991). 
~; Import into peroxisomal ghosts (Santos et at., 1988a and 1988b; Wiemer et 
al., 1989). Targeting of prethiolase-CAT to peroxisomal ghosts in group V 
cells is very weak and can only be detected in 25-50% of the cells expressing 
the reporter protein. 
injected per cell to assess import. The high sensitivity of the 
system is a reflection of the amplification by transcription 
and translation steps, and of the strength in human fibro- 
blasts of the promoters used (cytomegalovirus and Rous sar- 
coma virus) (Fig. 1). 
PTS1 comprises a COOH-terminal tripeptide, SKL, and 
firefly luciferase was chosen as the reporter protein for this 
import route. A prethiolase-CAT fusion protein was used as 
the reporter protein for import via the PTS2 route. Targeting 
was assessed by processing the cells for immunofluorescence 
18 h after microinjection ofthe expression constructs encod- 
ing the reporter proteins. In control cells, expression of both 
the PTS1 and PTS2 reporter proteins gave rise to a punctate 
pattern of labeling (Fig. 2, A and C), which was taken to be 
indicative of targeting: targeting of the reporter proteins to 
a peroxisomal compartment was assessed by double-label 
immunofluorescbnce using antibodies directed against he 
69-kD PMP, a well-established marker of the peroxisomal 
membrane (Fig. 2 B). 
Targeting via the PTS1 and PTS2 Routes 
in Groups I-V 
Luciferase xpressed in complementation group I cells gave 
rise to a pattern of labeling indistinguishable from that in 
control cells, and the peroxisomal nature of this compart- 
ment was confirmed by colocalization with the 69-kD per- 
oxisomal membrane protein (Fig. 2, D and E). Complemen- 
tation groups II-V allcontain peroxisomal ghosts (Fig. 2, H, 
K, N, and Q, respectively), indicating that targeting of the 
69-kD peroxisomal membrane protein is still functional in 
the complementation groups used in this study. However, lu- 
ciferase xpressed in cells from groups II-V gave rise to a 
Figure 3. Precursor thiolase is protected from egradation by pro- 
teinase K in group IV cells only. Fibroblasts from a control subject 
and from each of the complementation groups were permeabilized 
with 125 ttg/ml digitonin and incubated at 4°Cfor the times indi- 
cated in the presence or absence of 40 t~g/ml proteinase K and Tri- 
ton X-100, which was added to disrupt intracellular membranes. 
0.2% Triton was sufficient to observe digestion of precursor thio- 
lase in group IV cells, whereas 0.5% Triton was required before 
digestion of mature thiolase was observed in control cells. The ar- 
rows indicate he positions of precursor thiolase (44 kD) and ma- 
ture thiolase (41 kD). 
pattern of labeling characteristic for a protein with a cyto- 
plasmic location (Fig. 2, G, J, M, and P), and no association 
with the peroxisomal membranes could be detected. Identi- 
cal patterns of staining were seen after expression of CAT- 
SKL (not shown), a second reporter protein for the SKL im- 
port route. 
Expression of prethiolase-CAT in cells from comple- 
mentation groups I-l]/ gave rise to a diffuse pattern of 
fluorescence (Fig. 2, F, I, and L); no association with the 
peroxisomal membranes could be detected, not even in 
complementation group I fibroblasts, which contain mor- 
phologically normal, catalase- and luciferase-positive p r- 
oxisomes. Prethiolase-CAT expressed in complementation 
group V fibroblasts gave rise to a weak particulate pattern 
of labeling in only some (25-50%) of the cells expressing the 
reporter protein (Fig. 2 R), the expression pattern being 
diffuse in the remaining cells. In group IV cells, however, the 
PTS2 reporter protein gave rise to a strong particulate pat- 
tern of labeling in virtually all the cells expressing the 
reporter protein (Fig. 2 O): the structures labeled resemble 
peroxisomal ghosts (Fig. 2 N). These results are summa- 
rized in Table I. 
Figure 2. Panctate fluorescence as an indication for import of the reporter proteins into peroxisomes. The subcelhilar localization of lu¢ifer- 
ase (left pane/s), 69-kD PMP (center panels ), and prethiolase-CAT (r/ght pane/s).is shown in fibroblasts from a control subject (C)and 
from complementation groups I-V (I-V). Luciferase (PTS1 reporter) and prethiolase-CAT (PTS2 reporter) were produced in the cells from
microinjected expression constructs. Double labeling in control (.4, B) and group I (D, E) ceils shows that luciferase coloealizes with the 
69-kD PMP, whereas the pattern of immunofluorescence i  groups II-V expressing luciferase is diffuse (G, J, M, and P). Expression of 
prethiolas~CAT gives rise to a pattern of fluorescence that in groups I-HI is diffuse (F, 1, and L), in group IV is particulate (O), and 
in group V is sometimes weakly particulate (R) and sometimes diffuse. 
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Figure 5. Colocalization fprethiolase-CAT, 69-kD PMP and endogenous thiolase using double-label immunofluorescence. Prethiolase- 
CAT (A) colocalizes with endogenous thiolase (B) in group IV cells expressing the PTS2 reporter protein, and endogenous thiolase (C) 
colocalizes with 69-kD PMP in group IV cells (D). 
Protease Protection of Endogenous Thiolase 
in Groups I -V  
If import via the PTS2 pathway isintact, thiolase will be pro- 
tected from protease digestion because of its presence within 
the peroxisomal membrane. Protease protection experiments 
were performed on digitonin-permeabilized c lls to inves- 
tigate the stability of endogenous thiolase in the five com- 
plementation groups. Digitonin disrupts membranes by 
complexing to cholesterol: we have used 125 ttg/ml digito- 
nin, and under these conditions, the plasma membrane (and 
other cholesterol-rich membranes) arc permeabilized, but 
the peroxisomal membrane, which contains relatively little 
cholesterol, remains intact (Wanders et ai., 1984; Aikawa et 
ai., 1991). As shown in Fig. 3, fibroblasts from complemen- 
ration groups I-V contain only the precursor form of thiolase 
(44 kD). In each of the complementation groups except 
group IV, precursor thiolase was degraded in the absence of 
Triton X-100; in complementation group IV, however, 
precursor thiolase remained protected from protease diges- 
tion at each of the time points investigated, which suggests 
that it is present within a membrane. 
Because the immanofluorescence andprotease protection 
experiments suggest that targeting and import via the PTS2 
Figure 4. Detection of endogenous thiolase using a monoclonal antibody. (A) Control fibroblasts; (B-F) fibroblasts from groups l-V, respec- 
tively. A typical pcroxisomal labeling pattern is seen in control cells (A), a very weak, diffuse pattern of labeling is found in groups I-HI 
(B-D), a strong particulate pattern of labeling in group IV (E), and a weak pattern of labeling in group V cells (F), which in some cells 
is particulate and in some cells is diffuse. 
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pathway are intact in group IV ceils, additional experiments 
were performed to further substantiate hese observations. 
ConJirmation of Thiolase Targeting to Peroxisomes in 
Group IV Cells 
The observations made using the trrS2 reporter protein were 
supported when endogenous thiolase in the cells was visual- 
ized using a monoclonal antibody directed against peroxi- 
somal thiolase. When processed for antithiolase immunoflu- 
orescence, cells from complementation groups I-IH showed 
a very weak, diffuse pattern of labeling (Fig. 4, B, C, and 
D, respectively) (I-Ieikoop et al., 1992c). In complementa- 
tion group V cells, a weak pattern of labeling was seen, 
which in some cells was particulate and in some cells was 
diffuse (Fig 4 F). In complementation group IV cells, how- 
ever, a strong particulate pattern of labeling was seen, and 
the structures labeled resembled peroxisomal ghosts (Fig. 4 
E). Double-labeling immunofluorescence showed that pre- 
thiolase-CAT expressed after microinjection (Fig. 5 A) 
colocalizes with endogenous thiolase in group IV cells (Fig. 
5 B). 
To determine whether endogenous thiolase colocalizes 
with the peroxisomal membranes in group IV cells, double- 
labeling immunofluorescence using the antithiolase mono- 
clonal and the anti-69 kD PMP polyclonal antibody was per- 
formed. Fig. 5 shows that the thiolase immunoreactivity in 
group IV cells (C) indeed colocalizes with the peroxisomal 
membranes (D). 
Thiolase is Imported into Peroxisomal Membranes in 
Group IV Cells 
Differential permeabilization with digitonin (25 ~g/ml) fol- 
lowed by immunofluorescence was used to determine 
whether prethiolase-CAT is present on the inside or the out- 
side of the peroxisomal membrane in group IV cells express- 
ing the PTS2 reporter protein. When the plasma membrane 
was permeabflized using low concentrations of digitonin, 
epitopes exposed only to the cytoplasm were accessible to 
labeling by an antibody. Under these conditions, antibodies 
directed against he 69-kD PMP labeled the peroxisomal 
membranes (Fig. 6 A), whereas adiffuse pattern of labeling 
was observed using anti-CAT antibodies in cells expressing 
the PTS2 reporter protein (Fig. 6 B). When Triton X-100 
was included in the permeab'dization, both the plasma mem- 
brane and the peroxisomal membrane were permeabilized. 
Under these conditions, particulate pr thiolase-CAT could 
be detected (Fig. 6 C). The same results were obtained using 
an antithiolase monoclonal antibody to detect endogenous 
thiolase (not shown); thiolase labeling could be detected 
Figure 6. Differential permeabilization shows that the PTS2 
reporter protein is present inside the peroxisomal membranes in 
group IV cells. Differential permeabilization was performed using 
25 /s.g/ml digitonin, which permeabilizes the plasma membrane 
only, or digitonin plus Triton X-1O0, which permeahilizes both the 
plasma membrane and the peroxisomal membrane. (A) Staini g for 
69-kD PMP labels the peroxisomal membranes in group IV cells 
permeabilized with 25 ttg/ml digitonin. (B) When the PTS2 
reporter protein is labeled in group IV cells permeabilized with 25 
/zg/ml digitonin, a diffuse pattern of labeling is seen. (C)When Tri- 
ton and digitonin are used to permeahilize group IV cells express- 
ing th  PTS2 reporter protein, a particulate pattern of labeling of 
prethiolase-CAT can be detected. 
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Figure 7. Subcellular fractionation on Nycodenz equilibrium gra- 
dients shows that the peroxisomal ~ghosts " in group IV cells equili- 
brate in a low density fraction. Fractionation of (,4) control and (B) 
group IV fibroblasts. =, catalase; o, glutamate dehydrogenase 
(mitochondria); o,/~-hexosaminidase (lysosomes). Catalase (and 
other peroxisomal enzymes [not shown]) peak in fractions 6 and 
7 in control cells (A), with a small amount of catalase present at 
the top of the gradient. In Group IV cells (B), catalase is present 
exclusively at the top of the gradient, lmmunoblotting of group IV 
subcellular fractions (C) shows that precursor thiolase and 69-kD 
PMP peak in fractions 11and 12. 
only if Triton X-100 was included in the permeabilization. 
The ability to detect a particulate staining pattern for 
prethiolase-CAT and endogenous thiolase only when the 
peroxisomal membrane is permeabilized indicates that the 
ZIS2-containing proteins are present inside the membrane. 
Group IV  Ghosts Fractionate at Low Density 
Several investigations have indicated that peroxisomal ghosts 
fractionate ata lower density than peroxisomes from control 
cells (Santos et al., 1988; Gartner et al., 1991; Van Roer- 
mund et al., 1991). Subcellular f actionation was performed 
Figure 8. Most peroxisomal ghosts do not colocalize with lyso- 
somes in group IV cells. Double-label immunofluorescence shows 
the subcellular localization of thiolase (A) and glucocerebrosidase 
(B) in group IV cells. Superimposition of the pattern of labeling 
in (,4) onto that in (B) shows that most f he thiolase-containin~ 
particles do not colocalize with lysosomes. The arrow indicates an
area in which there is clearly no overlap of these two compartments. 
to investigate whether the prethiolase-containing particles in 
group IV cells also fractionate ata lower density than peroxi- 
somes from control cells. Fig. 7 indicates that this was the 
case. In control cells, peroxisomes equilibrated in fractions 
6 and 7, and they were well separated from the other organel- 
lar peaks (Fig. 7 A). In complementation group IV cells, 
however, catalase activity was found at the top of the gradient 
(Fig. 7 B), which is compatible with the diffuse pattern of 
labeling seen when catalase is visualized in group IV cells 
using immunofluorescence (Brnl et al., 1988). In contrast to 
catalase, however, thiolase and the 69-kD PMP immunore- 
activities migrated into the gradient and peaked in fractions 
11 and 12 (Fig. 7 C), showing overlap with the lysosomal 
marker enzyme activity. Overlap with the lysosomai corn- 
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partment has been investigated in complementation groups 
II and llI using double-label ectron microscopy (Heikoop 
et al., 1992b). Heikoop et ai. found that >~80% of the 69-kD 
PMP-containing peroxisomal ghosts howed labeling with 
anti-a-glucosidase and antiglucocerebrosidase, indicating 
that most of these structures are lysosomal compartments in 
groups II and 1-ft. We have investigated whether the thiolase 
labeling in group IV cells overlaps with that of the lysosomal 
enzyme glucocerebrosidase using double-labeling immu- 
nofluorescence. Asshown in Fig. 8, the immunofluorescence 
staining patterns are strikingly different in general appear- 
ance, and most of the particles taining for thiolase (A) are 
clearly separated from the glucocerebrosidase-containing 
lysosomes (B). Santos et al. (1988b) also found that most of 
the peroxisomal ghosts do not colocalize with lysosomes in
the Zellweger cell lines that they studied. 
Thiolase Labeling is Associated with Multiple 
Membranes in Group IV  Cells 
Double-label lectron microscopy was performed to inves- 
tigate whether a membrane could be visualized associated 
with the thiolase labeling in group IV cells. The electron 
micrographs shown in Fig. 9 clearly indicate that thiolase 
labeling is enclosed by a membrane that contains the 69-kD 
PMP. Many of the residual "organelles" found were bounded 
by more than one membrane, and in these cases, the thiolase 
labeling is localized more to the periphery of the organdie. 
Several of the "organelles" appear to contain internal mem- 
branes, which in one example separate differences in elec- 
tron density in the matrix. The appearance of these or- 
ganelles is reminiscent of the thiolase-containing organelles 
found in the S. cerevisiae mutant paslO (Van der Leij et al., 
1992). 
Discussion 
A promising line of research to gain insight into peroxisome 
biogenesis and the role of the components contributing to it 
is the characterization ofceils impaired in the assembly of 
the organdie. Such cells are available in the form of fibro- 
blasts derived from patients who suffer from peroxisome as- 
sembly disorders. We have studied the capacity of these 
fibroblasts to import PTS1- or PTS2-containing proteins into 
peroxisomes orresidual peroxisomal structures by microin- 
jection of plasmids encoding reporter proteins for each im- 
port pathway. Our results upport the existence of differential 
import deficiencies: (a) loss of PTS1 import (complementa- 
tion group IV); (b) loss of PTS2 import (group I); and (c) 
loss of both import routes (groups II, 1]/, and V). 
Loss of PTS1 import in complementation group IV, a 
"generalized" isorder of peroxisome assembly, is shown by 
the incompetence of the peroxisomal membranes in group 
IV cells to import luciferase produced from a microinjected 
expression plasmid. This result agrees with and extends the 
observation made by Walton et al. (1992) that microinjected 
luciferase protein fails to be imported in two Zellweger cell 
lines. Notwithstanding the presence of ghostlike residual 
peroxisomal structures in group IV cells, which are gener- 
ally considered tobe import incompetent, we have found that 
the PTS2 import pathway is still functional. This is based on 
the following observations: (a) prethiolase-CAT gives rise to 
punctate fluorescence; (b) prethiolase-CAT can be un- 
masked to give punctate fluorescence only after permeabili- 
zation of the peroxisomal membrane in the presence of 
Triton X-100; (c) endogenous thiolase is protected from pro- 
tease digestion in permeabilized group IV cells; and (d) 
prethiolase-CAT and endogenous thiolase colocalize with 
69-kD PMP-containing membranes in group IV cells as 
shown by immunofluorescence, immunoelectron micros- 
copy, and Nycodenz gradient subcellular f actionation. Fur- 
thermore, the possible presence of the bulk of the peroxi- 
somal structures in group IV cells within lysosomes was 
excluded by the absence of colocalization with the lysosomal 
enzyme glucocerebrosidase. Taken together, these results in- 
dicate that group IV is a true differential import mutant. A 
similar phenotype has been demonstrated in the S. cerevisiae 
peroxisome assembly mutant paslO. In both cell types, 
peroxisomes axe reduced to abnormal-looking membranous 
structures that are capable of importing thiolase but not 
SKL-containing proteins. The PASIO gene has been cloned 
by functional complementation of the paslO mutant (Van der 
Leij et al., 1993), and a homologue has been characterized 
from P. pastoris (McCollum et al., 1993). It encodes a pro- 
tein of the tetratricopeptide repeat family that directly rec- 
ognizes the SKL import motif (McCollum et al., 1993) 
(Franse, M. M., personal communication), supporting its 
direct role in the protein import process. Antibodies raised 
against he S. cerevisiae PAS10 protein recognize a specific 
peroxisomal protein from rat liver and human fibroblasts, 
and we are currently cloning the cDNA encoding this pro- 
tein, This will enable us to test he interesting possibility of 
whether group IV cells can be complemented by expression 
of the PAS10p homologue. 
Loss of PTS2 import is observed in complementation 
group I (RCDP) fibroblasts. This is based on (a) the lack of 
detectable import of prethiolase-CAT after expression of the 
PTS2 reporter protein in group I fibroblasts; and (b) the sen- 
sitivity of endogenous thiolase to protease digestion in per- 
meabilized group I cells. The competence of the PTS1 path- 
way can be inferred from the equilibration of acyl-CoA 
oxidase (an SKL-containing enzyme) at normal density after 
subcellular f actionation of RCDP cells (Balfe et al., 1990), 
and it is confirmed by the appearance of punctat¢ fluores- 
cence after expression of luciferase in group I cells. The rea- 
son this differential protein import loss has not been noted 
before may be because of the finding by Balfe et al. (1990) 
that precursor thiolase present in low density fractions of an 
RCDP subcellular gradient isresistant to proteinase K diges- 
tion. In contrast, we have found that precursor thiolase is not 
protected from degradation by proteinase K in permeabilized 
RCDP (group I) ceils. The clinical phenotype of RCDP is 
Figure 9. Colocalization f69-kD PMP and thiolase in aberrant membranous structures in group IV cells. 69-kD PMP, 5 nm gold; thiolase, 
10 am gold. The e|eetron micmgraphs indicate that most of the structures found are larger than peroxisomes from control ceils, and several 
of the structures contain multiple membranes. 
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Figure IO. Human and S. cerevisiae cells deficient in pemxisome 
assembly display similar phenoWpes. Peroxisomes in complemen- 
ration group I and S. cerevisiae past are morphologically normal 
and are able to import PTSl-containing proteins but not PTS2- 
containing proteins into their matrix. In complementation group IV 
and S. cerevisiae paslO, atypical membranous structures are pres- 
ent that are able to import PTS2- but not PTSl-containing proteins. 
NALD, neonatal form ofadrenoleukodystrophy. 
thought o arise from an inability to synthesize plasmalo- 
gens: Wanders et al. have found a single enzyme deficiency 
of dihydroxyacetonephosphate acyRransferase (1992) or 
alkyldihydroxyacetonephosphate synthase (1993) in two 
RCDP patients. The finding of additional complementation 
groups amongst RCDP patients (Moser, A., personal com- 
munication) supports the view that several (at least four) 
genetic defects could give rise to impairedplasmalogen sy - 
thesis. The apparent inconsistency between our results and 
those of Balfe et al. may, therefore, result from the use of 
RCDP cells belonging to different complementation groups. 
Again, the phenotype of the group I fibroblasts is strik- 
ingly similar to that of an S. cerevisiae mutant. The peroxi- 
somes present in both group I fibroblasts (Heikoop et al. 
1991) and S. cerevisiae pasT cells (Van der Leij et al., 1992) 
are morphologically normal and are capable of importing 
PTSl-containing proteins and catalase but not thiolase into 
their matrix. The number of proteins entering the peroxi- 
some via the PTS2 pathway appears to be rather limited com- 
pared to the number of proteins containing the PTS1. This 
may explain the difference in peroxisome morphology be- 
tween human complementatlon group I (S. cerevisiae pasT) 
and group IV (S. cerevisiae paslO). 
A generalized loss of import of PTS1- and PTS2-contain- 
ing proteins is illustrated by groups II, HI, and V. In these 
cells, only the routing of certain peroxisomal membrane pro- 
teins appears to be still functional. The phenotype of these 
cells may reflect a generalized impairment in the assembly 
or maturation of the organelle. Alternatively, by analogy 
with the import system for rnitochondriai proteins, the defect 
may lie at a point at which the PTS1 and PTS2 import path- 
ways converge, for example, at the protein translocation ap- 
paratus. 
Complementation group V is a special case in this last cat- 
egory. The diffuse pattern of fluorescence found after expres- 
sion of luciferase indicates the incapacity of the PTS1 import 
pathway. Expression of prethiolase-CAT, however, gives rise 
to a weak punctate fluorescence i  a fraction of the microin- 
jected cells. The reason for this intermediate phenotype is
unclear. The mutation i Fujiki's group F has recently been 
shown to reside in the gene encoding the 35-kD PAF (peroxi- 
some assembly factor) (Shimozawa et ai., 1992). Remark- 
ably, Shimozawa et ai. have found an identical mutation in 
PAF in our complementation group V (Shimozawa et al., 
1993). This mutation introduces a stop codon, giving rise to 
a COOH-terminal truncated protein. The truncated PAF 
protein may show some residual activity. Another possibility 
is that prethiolase-CAT is targeted to ghosts in group V 
cells, but fails to be imported. The sensitivity of endogenous 
thiolase to proteinase K digestion in permeabilized group V 
cells supports this possibility. 
In conclusion, we have found differential import deft- 
ciencies among the human peroxisome assembly disorders: 
the phenotypes found are analogous to phenotypes found 
amongst the S. cerevisiae peroxisome assembly mutants (see 
Fig. 10). The finding that differential protein import defi- 
ciencies also occur in the human peroxisome assembly dis- 
orders substantiates further that the mechanism of per- 
oxisomal protein import is strongly conserved, not only in 
the use of similar targetting sequences, but also in the pro- 
teins comprising the import machinery. 
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